In a study in mice, a wireless implant was able to release glucagon as an emergency treatment for hypoglycemia, a serious ...

MIT’s latest implantable device releasing glucagon automatically when blood sugar drops too low, tested in diabetic mice, ...

As rates of childhood obesity rise, clinicians call for increased data collection to support insurance coverage and safe use of glucagon-like peptide 1 (GLP-1) medications in children under 12 years.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.

Learn more about the gut microbiome's digestion of the amino acid tryptophan, which creates byproducts with potential for ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body shapes and sizes.

David J. Maron, MD, FASPC, president-elect of the American Society for Preventive Cardiology (ASPC), previews hot topics of interest at this year's congress and how lessons he has learned from current ...

MIT 3D prints glucagon-releasing implant for diabetic care. The quarter-sized reservoir sits under the skin and can be ...

MIT researchers develop a wireless implant that detects low blood sugar and releases glucagon, offering a potential safety ...

MIT engineers created an implantable device for diabetic patients that acts as an emergency device for when blood sugar hits ...

Resmetirom and glucagon receptor agonists were tied to lower liver fat and reduced alanine aminotransferase levels for people with metabolic-associated steatotic liver disease or metabolic ...

Trending News: Nature showcases incredible shape-shifting abilities in various animals for survival. From the mimic octopus's deceptive transformations to the puffer ...